Ekso Bionics (NASDAQ: EKSO) holder discloses 9.48% stake in Schedule 13G

Rhea-AI Filing Summary

Ekso Bionics Holdings, Inc. received a Schedule 13G reporting a significant ownership position in its ordinary shares. Investor Daniel Asher reports beneficial ownership of 321,763 shares, representing 9.48% of the class, with shared power to vote and dispose of these shares and no sole voting or dispositive power.

Related entity DBA Trading, LLC is identified as a reporting person with shared voting and dispositive power over 156,763 shares and a stated 4.62% of the class. The filing states that Asher is the beneficial owner of DBA Trading, LLC and is deemed to control voting and dispositive power over the shares held by that entity. The certification notes that the securities are not held for the purpose of changing or influencing control of Ekso Bionics.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

Ekso Bionics Holdings, Inc.

(Name of Issuer)

Ordinary shares, nominal value $0.01 per share

(Title of Class of Securities)

282644400

(CUSIP Number)

12/30/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 282644400

1

Names of Reporting Persons

DANIEL ASHER

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 321,763.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 321,763.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

321,763.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.48 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

CUSIP No. 282644400

1

Names of Reporting Persons

DBA Trading, LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 156,763.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 156,763.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

0.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

4.62 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Ekso Bionics Holdings, Inc.
(b)	Address of issuer's principal executive offices: 101 Glacier Point, Suite A San Rafael, CA 94901
Item 2.
(a)	Name of person filing: Daniel Asher, DBA Trading, LLC
(b)	Address or principal business office or, if none, residence: 1011 Lake St. Suite 311 Oak Park IL 60301
(c)	Citizenship: USA
(d)	Title of class of securities: Ordinary shares, nominal value $0.01 per share
(e)	CUSIP No.: 282644400
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: See Row 9 of cover page for each reporting person.
(b)	Percent of class: See Row 11 of cover page for each reporting person.
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: See Row 5 of cover page for each reporting Person.
	(ii) Shared power to vote or to direct the vote: See Row 6 of cover page for each reporting Person.
	(iii) Sole power to dispose or to direct the disposition of: See Row 7 of cover page for each reporting Person.
	(iv) Shared power to dispose or to direct the disposition of: See Row 8 of cover page for each reporting Person. Dan Asher is the beneficial owner of DBA Trading, LLC and deemed to control share voting and dispositive power over the shares held by them.
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

DANIEL ASHER

Signature:	/s/ Daniel Asher
Name/Title:	Daniel Asher
Date:	01/08/2026

DBA Trading, LLC

Signature:	/s/ Fred Goldman
Name/Title:	Fred Goldman, Member
Date:	01/08/2026

Exhibit Information

99.1 Joint Filing Agreement of the Reporting Persons 99.2 Transactions of the Reporting Persons

FAQ

What ownership stake in Ekso Bionics (EKSO) does Daniel Asher report?

Daniel Asher reports beneficial ownership of 321,763 Ekso Bionics ordinary shares, representing 9.48% of the outstanding class, with shared voting and dispositive power.

Who are the reporting persons in this Ekso Bionics Schedule 13G filing?

The reporting persons are Daniel Asher and DBA Trading, LLC. Asher is identified as the beneficial owner of DBA Trading, LLC and is deemed to control voting and dispositive power over shares held by that entity.

How many Ekso Bionics shares are associated with DBA Trading, LLC?

DBA Trading, LLC is reported as having shared voting and dispositive power over 156,763 Ekso Bionics shares, and this position is stated as representing 4.62% of the class.

Is this Ekso Bionics (EKSO) ownership filing intended to influence control of the company?

The certification states that the securities were not acquired and are not held for the purpose of changing or influencing the control of Ekso Bionics, and are not held in connection with any transaction having that purpose or effect.

What type of securities are covered in this Ekso Bionics Schedule 13G?

The filing covers ordinary shares of Ekso Bionics Holdings, Inc. with a nominal value of $0.01 per share, identified by CUSIP number 282644400.

What is the date of the event that triggered this Ekso Bionics Schedule 13G?

The date of the event requiring the filing is listed as December 30, 2025.